ArticleLaryngoscope investigative otolaryngology2026
Nine Years of Experience With Bonebridge: Long-Term Clinical and Audiological Outcomes.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The active bone conduction hearing implant Bonebridge is a therapeutic option for hearing rehabilitation of patients with conductive and mixed hearing loss, as well as for those with unilateral sensorineural hearing loss. It has demonstrated satisfactory audiological gain, comparable to conventional hearing aids and percutaneous bone-anchored hearing implants, with low rates of surgical and postoperative complications. However, long-term follow-up data are scarce. Methods: This retrospective, observational, and longitudinal study included 26 patients who underwent Bonebridge implantation between 2014 and 2021 at the Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo. We reviewed medical records, audiological evaluations, and satisfaction questionnaires collected at activation, 12 months post-surgery, and at the latest assessment and also analyzed the incidence of clinical and technical complications during follow-up. Results: The mean follow-up period was 68.8 months (±21.5), ranging from 24 to 108 months. Functional gain decreased, while Sentence Recognition Threshold improved over time; effective gain and Speech Recognition Score remained stable. User satisfaction also remained stable, except in the service and costs domains of the SADL questionnaire. Conclusion: Bonebridge provides safe and effective long-term audiological rehabilitation for adults and children with conductive or mixed hearing loss, with stable outcomes over time. Level of Evidence: 3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.